stem cell

Explore how researchers use organoids to understand tissue regeneration and develop novel therapies.

Scientists use innovative stem cell culture models to progress retinal cell therapy research.

In this webinar, Alex Rimmer, Samuel East, and Catriona Jamieson will discuss how they developed low-cost, animal-free culture media for cellular agriculture.

A streamlined protocol for generating iNK cells from PSC spheroids

Induced pluripotent stem cell-derived microglia generated with precision cell reprogramming technology can create more reliable in vitro assays.

A new approach using two types of recombinases lets scientists insert larger DNA payloads into human pluripotent stem cells faster than ever before. 

A happenstance collaboration between biologists and roboticists led to the birth of a strange creation: living machines derived from frog stem cells.

A new culture medium helps researchers efficiently expand pluripotent stem cell cultures for therapeutic research applications.

Accelerating the production of induced pluripotent stem cell-derived models accelerates publishable neuroscience research.

Meritxell Huch tackled her pipedream of growing three-dimensional pancreatic tissue in a dish.

Explore the latest in organoid production for studying development, disease, and drug screening.

In this webinar, Benjamin Freedman talks about the importance of organoids in modeling organ function and disease.

In this webinar, Benton Berigan will highlight the value of combining multimodal data, including spatial information, to understand complex immunological processes.

Cutting edge technology delivers cytokines with high purity, high bioactivity, high batch-to-batch consistency, and high stability.

Discover how a new procedure reverses the polarity of typical basolateral-out organoids to form versatile apical-out organoids.

The latest synthetic and chemical reagents offer researchers more flexibility, stability, and consistency when working with their cells.

In this webinar, Bryan McQueen will discuss how a novel in vitro model of inflammatory bowel disease paves the way toward scientific discovery and developing cost-effective therapies.

Khalid Shah engineers stem cells to deliver cancer therapeutics directly to tumors, thereby increasing their efficacy.

Clive Svendsen, Meritxell Huch, Ameen Salahudeen, and Maksim Plikus will discuss the latest advances in using patient-derived stem cells to create more accurate disease models.